Results 251 to 260 of about 70,301 (300)
Some of the next articles are maybe not open access.

Ocular Drug Delivery

2016
Although the eye is an accessible organ for direct drug application, ocular drug delivery remains a major challenge due to multiple barriers within the eye. Key barriers include static barriers imposed by the cornea, conjunctiva, and retinal pigment epithelium and dynamic barriers including tear turnover and blood and lymphatic clearance mechanisms ...
Burcin, Yavuz, Uday B, Kompella
openaire   +2 more sources

Review of Ocular Drug Delivery

Current Drug Delivery, 2006
Successful treatment of eye diseases requires effective concentration of drug at the eye for sufficient period of time. Conventional ocular drug delivery including eye drops, systemic administration, ophthalmic ointments, is no longer sufficient to combat ocular diseases.
Yasmin, Sultana   +3 more
openaire   +2 more sources

Advances in Ocular Drug Delivery

Current Eye Research, 2012
Eye drops have long been the primary ocular drug delivery dosage form used to treat ocular disorders ranging from superficial conditions to intravitreal diseases. The ocular anatomical structure and physiological protective mechanisms are one of the most formidable barriers to drug penetration that have significantly reduced the drug's efficacy and ...
Rawas-Qalaji, Mutasem   +1 more
openaire   +3 more sources

Nanomaterials for Ocular Drug Delivery

Macromolecular Bioscience, 2012
AbstractEfficient drug delivery to the eye remains a challenging task for pharmaceutical scientists. Due to the various anatomical barriers and the clearance mechanisms prevailing in the eye, conventional drug delivery systems, such as eye drop solutions, suffer from low bioavailability.
Shengyan, Liu   +2 more
openaire   +2 more sources

Drug delivery from ocular implants

Expert Opinion on Drug Delivery, 2006
Developing an intraocular drug delivery system (DDS) is urgently needed because most vitreoretinal diseases are refractory to conventional pharmacological approaches; eye drops and systemically administered drugs cannot deliver therapeutic drug concentrations into vitreoretinal tissue. Intraocular DDSs address this problem.
Tsutomu, Yasukawa   +4 more
openaire   +2 more sources

Nanotechnology in ocular drug delivery

Drug Discovery Today, 2008
Despite numerous scientific efforts, efficient ocular drug delivery remains a challenge for pharmaceutical scientists. Most ocular diseases are treated by topical drug application in the form of solutions, suspensions and ointment. These conventional dosage forms suffer from the problems of poor ocular bioavailability, because of various anatomical and
Sanjeeb K, Sahoo   +2 more
openaire   +2 more sources

Recent advances in ocular drug delivery

Drug Development and Industrial Pharmacy, 2012
Amongst the various routes of drug delivery, the field of ocular drug delivery is one of the most interesting and challenging endeavors facing the pharmaceutical scientist. Recent research has focused on the characteristic advantages and limitations of the various drug delivery systems, and further research will be required before the ideal system can ...
Djamila, Achouri   +3 more
openaire   +2 more sources

Ocular drug delivery conventional ocular formulations

Advanced Drug Delivery Reviews, 1995
Abstract Within the last few decades, in response to the advent of potent and versatile therapeutic agents, the diversity of conventional ophthalmic formulations has gradually evolved, extending well beyond simple solutions, and now includes a variety of types of drug administration.
openaire   +1 more source

Redefining ocular drug delivery

The Ocular Surface, 2022
Allisa J. Song   +2 more
openaire   +2 more sources

Ocular drug delivery in veterinary medicine

Advanced Drug Delivery Reviews, 1997
This paper provides a comprehensive overview of the various approaches currently used in the development of ocular drug delivery systems for the treatment of ocular diseases in animals. It is obvious from the literature that most of the products that are currently available are derived from human medicine without consideration given to the differences ...
Baeyens, Vincent   +5 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy